BLACK WEEKSViaalid −15% · komplektid −10% · muu −5%koodigaTasuta tarne Saksamaal alates €200

See leht on tõlgitud automaatselt ja võib sisaldada vigu. Kas eesti keel on sinu emakeel? Ootame hea meelega sinu tagasisidet ja parandusi.Saada tagasisidet

The Peptide Desk The Peptide Desk
Ovagen, toote foto
Bioregulators

Ovagen

Bioregulators

  • Saadetakse Saksamaalt

Tellimus

Ühiku hind - Black Weeksi ajal tasuta tarne Saksamaal alates 200 €
  • DHL koos jälgimisega
  • Diskreetne pakend

4.6 5-st Trustpilotis73 arvustust

Lühidalt

Ovagen arvudes

Põhinäitajad meie leksikonist.

Täielik leksikoni artikkel
Class
Short bioregulator peptideKhavinson cytogen
Use
Subcutaneousin mg
Sizes
20 mg1 size in the shop

Teadmised

Kõik teemal Ovagen

Telli kohe kaasa

Mida sul sellega vaja on

Bakteriostaatiline vesi lisatakse ostukorvi automaatselt. Süstlad ja lapid ühe klõpsuga.

Insuliinisüstlad

10 tk · 5.50 €

Alkoholilapid

50 tk · 10 €

Kui palju vett?

Ühikud süstlal sinu viaali suuruse jaoks.

Ava kalkulaator →

FAQ

Korduma kippuvad küsimused

Allikad iga vastuse juurde: leksikoni artikkel

Kas sul on veel küsimusi?

Kirjuta meile, meie meeskond aitab sind.

What is Ovagen?

According to a review by the Khavinson group, the tripeptide Glu-Asp-Leu (EDL). The group lists it as a protective peptide for the kidneys and liver. PubMed has no study under the name Ovagen, the papers call it EDL or T-35.

What do the studies on EDL show?

In rats with kidney damage from the antibiotic gentamicin or from interrupted blood flow, EDL prevented a drop in urine output and a build-up of waste products. Protein and sodium in the urine fell, antioxidant enzymes did not drop critically. The abstract gives no percentages.

How well is the effect on the liver supported?

Weakly. For the liver the review cites a patent of the group as evidence, no published study with EDL in the liver was found. The related short peptide Livagen stimulated the growth of liver tissue pieces in tissue culture.

How is Ovagen supposed to work?

The Khavinson group suggests that short peptides reach the cell nucleus and bind to DNA. Modelled on the computer, EDL bound the same DNA sequence as Bronchogen and could enter cells via the transporter LAT1. In kidney cell cultures the enzyme MMP-14 was its target. This is only shown in models and cell cultures.

Has Ovagen been studied in humans?

No. ClinicalTrials.gov lists no trial with Ovagen or EDL (as of 26 Oct 2026). The 2002 review describes clinical use of tissue extracts such as Epithalamin and Thymalin, not of Ovagen.

Which side effects are known?

There are no solid data because Ovagen has never been tested in a registered human trial. Missing reports are not proof of safety.

Seotud

Seotud tooted